Lombardi Comprehensive Cancer Center is to a state-of-the-art cancer center housing more than 240,000 square feet of clinic and research space. Lombardi’s mission is to provide the most advanced treatments available, to train future cancer specialists, and to cure cancer in its many forms. Lombardi is one of only 45 comprehensive cancer centers in the nation, and the only one in the Washington metropolitan area.
In order to obtain the comprehensive designation, which is the highest ranking the National Cancer Institute (NCI) gives, a center must meet strict criteria that include a strong core of basic laboratory research in several fields, the ability to translate those research findings into therapies that can one day be used to treat patients, a program of high-priority clinical trials, and a commitment to community service and outreach activities related to cancer prevention and control.
Louis Weiner, M.D.
Director of the Lombardi Comprehensive Cancer Center
Chair of the Department of Oncology
Associate Vice President of GUMC
Professor of Oncology
Education and training at the Lombardi Comprehensive Cancer Center spans all levels of learning, from programs for minority high school students to postdoctoral fellowships and beyond. The School of Medicine’s Department of Oncology is comprised of faculty members from Lombardi. The cancer center also administrates four master’s programs (in biostatistics, health physics, tumor biology, and a joint program in cancer genetics, epidemiology, and control), as well as the PhD or combined MD/PhD program in tumor biology. Additionally, three postdoctoral training programs are offered at Lombardi: a medical genetics fellowship, clinical fellowships in hematology/oncology and palliative care, and research fellowships in tumor biology.
Lombardi receives more than $100 million in research grants, has nearly 200 full-time faculty members and 220 ongoing clinical trials. There are six established research programs at Lombardi: the Breast Cancer Program, the Cancer Control Program, the Cancer Genetics and Epidemiology Program, the Growth Regulation of Cancer Program, the Molecular Targets and Developmental Therapeutics Program, and the Radiation Biology and DNA Repair Program. In addition to these programs, GUMC’s Drug Discovery Program works closely with Lombardi developing cancer drugs.
Other programs associated with oncology work at Georgetown University Medical Center include
The Capital Breast Care Center, a community initiative by Lombardi, seeks to provide and maximize comprehensive culturally-appropriate breast cancer screening services to women of the DC metropolitan area, regardless of the ability to pay, through clinical services, education and research.
The Betty Lou Ourisman Breast Health Center, which combines in one location all the services needed for optimal breast health.
The Jess and Mildred Fisher Center for Familial Cancer Research, which offers patients diagnosed with cancer or with a family history of cancer the opportunity to receive genetic counseling and testing.